GGAAF — NeuroMind AI Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +288.76 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NeuroMind AI Corp. is a Switzerland-based Public Company holding a collection of strategic IP assets in the AR/VR realm, focused on creating and delivering AI-enhanced neuro-immersive experiences with a spectrum of potential applications. It has been formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities, which the Company refers to as a target business. The Company is focused on technology companies operating within the Consumer Internet industry with a geographical presence in Europe, Israel, the United Arab Emirates or the United States.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- March 17th, 2021
- Public Since
- December 9th, 2021
- No. of Shareholders
- 6
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 228,200,000
- Address
- Bahnhofstrasse 3, HERGISWIL, 6052
- Web
- https://www.neuromind-ai.com
- Phone
- +41 null786079901
- Auditors
- /s/ Citrin Cooperman & Company, LLP
Latest News for GGAAF
Upcoming Events for GGAAF
Similar to GGAAF
0187279 BC
Pink Sheets on Nasdaq
0913693 BC
Pink Sheets on Nasdaq
Sanarco Funds
Pink Sheets on Nasdaq
9 Meters Biopharma
Pink Sheets on Nasdaq
Absolute Health and Fitness
Pink Sheets on Nasdaq
FAQ
As of Today at 19:49 UTC, shares in NeuroMind AI are trading at $5.38. This share price information is delayed by 15 minutes.
Shares in NeuroMind AI last closed at $5.38 and the price had moved by -56.61% over the past 365 days. In terms of relative price strength the NeuroMind AI share price has underperformed the S&P500 Index by -60.64% over the past year.
There is no consensus recommendation for this security.
Find out moreNeuroMind AI does not currently pay a dividend.
NeuroMind AI does not currently pay a dividend.
NeuroMind AI does not currently pay a dividend.
To buy shares in NeuroMind AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.38, shares in NeuroMind AI had a market capitalisation of .
Here are the trading details for NeuroMind AI:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: GGAAF
Based on an overall assessment of its quality, value and momentum NeuroMind AI is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NeuroMind AI. Over the past six months, its share price has underperformed the S&P500 Index by -21.8%.
As of the last closing price of $5.38, shares in NeuroMind AI were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NeuroMind AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NeuroMind AI's management team is headed by:
- Cem Habib - IND
- Michael Lahyani - CCH
- Eyal Perez - CHM